Search Results

Verogen, Inc. and Gene by Gene today announced a partnership to accelerate the adoption of forensic investigative genetic genealogy.

The two companies will collaborate to market Verogen’s forensically validated NGS workflows alongside QIAGEN’s full range of forensic-grade chemistries and sample prep automation.

Verogen Inc., a dedicated developer of human identification products for sequencing and analysis of forensic genomic samples, is building on its partnership with Cellmark Forensic Services.

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen Inc. today announced a partnership to provide laboratories with superior tools and comprehensive support for implementing next-generation sequencing (NGS) human identification workflows.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a commercialization partnership with San Diego-based human identification specialist Verogen that will provide customers of both companies with superior tools and comprehensive support for human identification (HID) workflows in their laboratories.

GEDmatch, a pioneer in consumer genealogy, announced that it has joined with forensic genomics firm Verogen, Inc. in a move that allows the company to ensure ongoing privacy protections and enhance the customer experience for users of its website.

The Center for Forensic Science Research & Education and Verogen have entered into a collaborative agreement to establish CFSRE as a leader in the field of forensic Next Generation Sequencing, also known as Massively Parallel DNA Sequencing.

Cellmark Forensic Services and Verogen have signed a collaboration agreement to establish Cellmark as a United Kingdom center of excellence for forensic Next Generation Sequencing, also known as Massively Parallel DNA Sequencing.

Verogen, Inc., the world’s first sequencing company solely dedicated to forensic science, announced today that it will begin taking orders and shipping products in the Americas (including the U.S., Canada, Mexico, Central and South America) beginning February 22, 2018 and in EMEA (Europe, Middle East, Africa) and China beginning March 9, 2018.